Suchergebnisse - "Cioffi, Giovanni"

PubPharm (253)

51

Usefulness of CHA2 DS2‐VASc score to predict mortality and hospitalization in patients with inflammatory arthritis

enthalten in: International Journal of Rheumatic Diseases | 2020

von Cioffi, G. | Viapiana, O. | Orsolini, G. | +9

52

Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis

enthalten in: ACR Open Rheumatology | 2020

von Cioffi, G. | Giollo, A. | Orsolini, G. | +8

53

Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population

enthalten in: Cardiovascular drugs and therapy | 2019

von Giorda, C. | Cioffi, G. | Lucci, D. | +72

54

Incidence and predictors of new onset left ventricular diastolic dysfunction in asymptomatic patients with rheumatoid arthritis without overt cardiac disease

enthalten in: Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace | 2019

von Dal Piaz, E. | Cioffi, G. | Ognibeni, F. | +8

CommentIn: Monaldi Arch Chest Dis. 2019 Sep 10;89(3):. - PMID 31505913

55

Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population

enthalten in: Cardiovascular drugs and therapy | 2019

von Giorda, C. | Cioffi, G. | Lucci, D. | +5

56

Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population

enthalten in: Cardiovascular drugs and therapy | 2019

von Giorda, C. | Cioffi, G. | Lucci, D. | +5

57

Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population

enthalten in: Cardiovascular drugs and therapy | 2019

von Giorda, C. | Cioffi, G. | Lucci, D. | +5

58

P169 Relationship Between Common Carotid Distensibility/Aortic Stiffness and Left Ventricular Morphology and Function in Rheumatologic Patients

enthalten in: Artery research | 2018

von Bevilacqua, M. | Dalbeni, A. | Tagetti, A. | +8

59

Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg study

enthalten in: European journal of heart failure | 2018

von Gori, M. | Redfield, M. | Calabrese, A. | +10

60

Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction : a community-based study

enthalten in: European journal of heart failure | 2018

von Iorio, A. | Senni, M. | Barbati, G. | +9

CommentIn: Eur J Heart Fail. 2018 Sep;20(9):1267-1268. - PMID 29917297